Medpace Holdings (MEX:MEDP) Days Sales Outstanding : 49.33 (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Medpace Holdings Days Sales Outstanding?

Medpace Holdings's average Accounts Receivable for the three months ended in Sep. 2024 was MXN5,677 Mil. Medpace Holdings's Revenue for the three months ended in Sep. 2024 was MXN10,501 Mil. Hence, Medpace Holdings's Days Sales Outstanding for the three months ended in Sep. 2024 was 49.33.

The historical rank and industry rank for Medpace Holdings's Days Sales Outstanding or its related term are showing as below:

MEX:MEDP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.45 Med: 45.46 Max: 52.39
Current: 49.38

During the past 11 years, Medpace Holdings's highest Days Sales Outstanding was 52.39. The lowest was 36.45. And the median was 45.46.

MEX:MEDP's Days Sales Outstanding is ranked better than
71.36% of 213 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.69 vs MEX:MEDP: 49.38

Medpace Holdings's Days Sales Outstanding increased from Sep. 2023 (46.04) to Sep. 2024 (49.33).

Medpace Holdings Days Sales Outstanding Historical Data

The historical data trend for Medpace Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Days Sales Outstanding Chart

Medpace Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

45.89

51.08

45.41

46.44

50.40

Medpace Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															46.04	49.43	49.36	46.43	49.33

Competitive Comparison of Medpace Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, Medpace Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medpace Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Days Sales Outstanding falls into.

Medpace Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medpace Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4155.943	+	4683.738)	/	2 )	/	32010.75	*	365
=	4419.8405					/	32010.75	*	365
=	50.40

Medpace Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (5352.933	+	6000.698)	/	2 )	/	10501.172	*	365 / 4
=	5676.8155					/	10501.172	*	365 / 4
=	49.33

Medpace Holdings (MEX:MEDP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medpace Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (MEX:MEDP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MEDP:USA 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.